Tegaserod
Tegaserod is a pharmaceutical drug with 23 clinical trials. Historical success rate of 61.9%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
17
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
61.9%
13 of 21 finished
38.1%
8 ended early
0
trials recruiting
23
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis
Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.
Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.
Clinical Trials (23)
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis
Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.
Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.
Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain
The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)
Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation
A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation
A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)
Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation
Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation
The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.
Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 23